Vasosol Organ Perfusion Solution and Medtronic Portable Bypass System
Phase 1
Completed
- Conditions
- Liver TransplantationOrgan Preservation
- Registration Number
- NCT00879268
- Lead Sponsor
- Polyak, Maximilian
- Brief Summary
This is a pilot trial of centrifugal machine preservation of donor livers for transplantation using a novel preservation solution.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
- Primary/ Solitary Liver Transplant
- Lab MELD<35
- Donor age <65
Exclusion Criteria
- Donor Liver > 30% Macrosteatosis
- DCD donor liver
- Multi-organ Recipient
- Recipient in ICU
- Retransplant
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms does Vasosol solution target for liver preservation in transplantation?
How does centrifugal machine preservation compare to traditional cold storage methods in liver transplant outcomes?
Which biomarkers are associated with successful liver graft function after machine perfusion with Vasosol?
What adverse events have been reported in phase 1 trials of liver machine perfusion solutions like Vasosol?
Are there alternative organ preservation solutions or systems competing with Vasosol in liver transplantation research?